BI 690517

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for BI 690517, covering 2024-08-29 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) [Phase 3]

See pricing